Skip to main content
Premium Trial:

Request an Annual Quote

Cyntellect Opens UK Office to Expand European Market

NEW YORK (GenomeWeb News) – US-based cytometry firm Cyntellect today announced the opening of its European operations in Newport, UK.

Cyntellect said that a team of sales, scientific, and service support staff throughout the UK, France, Germany, and the Netherlands will cover all of the European Union.

"With the formation of Cyntellect Europe, we will accelerate the commercialization of our products for applications in cell line development for biopharmaceuticals, drug discovery, and cancer research, including key applications utilizing stem cells," Cyntellect President and CEO Fred Koller said in a statement.

The San Diego-based company also said that it will formally launch two products to the European market at next week's MipTech Conference and Tradeshow in Basel, Switzerland: a cytometer for non-invasive in situ live-cell imaging; and a module to manage stem cell research processes in its flagship cell-processing workstation.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.